Hollsteen
← Take-Two

D&A

Flow – sum over the period · $M

QuartersFiscal years

$MD&A · Q1 FY2016: $7.0M · 10-Q 0001047469-15-006749 filed Aug 10, 2015D&A · Q2 FY2016: $7.0M · 10-Q 0001047469-15-008367 filed Nov 6, 2015D&A · Q3 FY2016: $8.0M · 10-Q 0001047469-16-010014 filed Feb 4, 2016D&A · Q4 FY2016: $7.0M · derived · 10-K 0001628280-17-005833 filed May 24, 2017D&A · Q1 FY2017: $7.0M · 10-Q 0001047469-16-014693 filed Aug 5, 2016D&A · Q2 FY2017: $7.0M · 10-Q 0001047469-16-016473 filed Nov 3, 2016D&A · Q3 FY2017: $7.0M · 10-Q 0001047469-17-000578 filed Feb 8, 2017D&A · Q4 FY2017: $8.0M · derived · 10-K 0001628280-18-006877 filed May 17, 2018D&A · Q1 FY2018: $8.0M · 10-Q 0001628280-17-007899 filed Aug 3, 2017D&A · Q2 FY2018: $19.0M · 10-Q 0001628280-17-011117 filed Nov 8, 2017D&A · Q3 FY2018: $8.0M · 10-Q 0001628280-18-001226 filed Feb 8, 2018D&A · Q4 FY2018: $9.0M · derived · 10-K 0001628280-19-006691 filed May 14, 2019D&A · Q1 FY2019: $9.0M · 10-Q 0001628280-18-010376 filed Aug 3, 2018D&A · Q2 FY2019: $10.0M · 10-Q 0001628280-18-013920 filed Nov 8, 2018D&A · Q3 FY2019: $10.0M · 10-Q 0001628280-19-001036 filed Feb 6, 2019D&A · Q4 FY2019: $11.0M · derived · 10-K 0001628280-20-008291 filed May 22, 2020D&A · Q1 FY2020: $11.0M · 10-Q 0001628280-19-010011 filed Aug 6, 2019D&A · Q2 FY2020: $12.0M · 10-Q 0001628280-19-013731 filed Nov 8, 2019D&A · Q3 FY2020: $12.0M · 10-Q 0001628280-20-001155 filed Feb 7, 2020D&A · Q4 FY2020: $13.0M · derived · 10-K 0001628280-21-010627 filed May 19, 2021D&A · Q1 FY2021: $12.0M · 10-Q 0001628280-20-011493 filed Aug 4, 2020D&A · Q2 FY2021: $14.0M · 10-Q 0001628280-20-015824 filed Nov 6, 2020D&A · Q3 FY2021: $14.0M · 10-Q 0001628280-21-001632 filed Feb 9, 2021D&A · Q4 FY2021: $15.0M · derived · 10-K 0001628280-22-014580 filed May 17, 2022D&A · Q1 FY2022: $12.0M · 10-Q 0001628280-22-021685 filed Aug 9, 2022D&A · Q2 FY2022: $16.0M · 10-Q 0001628280-22-028716 filed Nov 8, 2022D&A · Q3 FY2022: $16.0M · 10-Q 0001628280-22-001929 filed Feb 8, 2022D&A · Q4 FY2022: $16.0M · derived · 10-K 0001628280-23-019851 filed May 26, 2023D&A · Q1 FY2023: $22.0M · 10-Q 0001628280-22-021685 filed Aug 9, 2022D&A · Q2 FY2023: $30.0M · 10-Q 0001628280-22-028716 filed Nov 8, 2022D&A · Q3 FY2023: $35.0M · 10-Q 0001628280-23-002448 filed Feb 7, 2023D&A · Q4 FY2023: $36.0M · derived · 10-K 0001628280-24-024623 filed May 22, 2024D&A · Q1 FY2024: $40.0M · 10-Q 0001628280-23-028326 filed Aug 9, 2023D&A · Q2 FY2024: $45.0M · 10-Q 0001628280-23-037956 filed Nov 9, 2023D&A · Q3 FY2024: $43.0M · 10-Q 0001628280-24-003951 filed Feb 9, 2024D&A · Q4 FY2024: $43.0M · derived · 10-K 0001628280-25-026694 filed May 20, 2025D&A · Q1 FY2025: $45.0M · 10-Q 0001628280-24-036273 filed Aug 9, 2024D&A · Q2 FY2025: $47.0M · 10-Q 0001628280-24-045867 filed Nov 7, 2024D&A · Q3 FY2025: $50.0M · 10-Q 0001628280-25-004308 filed Feb 7, 2025D&A · Q4 FY2025: $88.0M · derived · 10-K 0001628280-26-037434 filed May 22, 2026D&A · Q1 FY2026: $50.0M · 10-Q 0001628280-25-038963 filed Aug 7, 2025D&A · Q2 FY2026: $49.0M · 10-Q 0001628280-25-050326 filed Nov 7, 2025D&A · Q3 FY2026: $49.0M · 10-Q 0001628280-26-005119 filed Feb 4, 2026D&A · Q4 FY2026: $50.0M · derived · 10-K 0001628280-26-037434 filed May 22, 2026D&A · Q1 FY2027: $48.0M · 10-Q 0001628280-26-054870 filed Aug 7, 202616.5a48.26.687.8aQ1 FY2016Q1 FY2027Q4 FY2022
$MD&A · Q4 FY2021: $15.0M · derived · 10-K 0001628280-22-014580 filed May 17, 2022D&A · Q1 FY2022: $12.0M · 10-Q 0001628280-22-021685 filed Aug 9, 2022D&A · Q2 FY2022: $16.0M · 10-Q 0001628280-22-028716 filed Nov 8, 2022D&A · Q3 FY2022: $16.0M · 10-Q 0001628280-22-001929 filed Feb 8, 2022D&A · Q4 FY2022: $16.0M · derived · 10-K 0001628280-23-019851 filed May 26, 2023D&A · Q1 FY2023: $22.0M · 10-Q 0001628280-22-021685 filed Aug 9, 2022D&A · Q2 FY2023: $30.0M · 10-Q 0001628280-22-028716 filed Nov 8, 2022D&A · Q3 FY2023: $35.0M · 10-Q 0001628280-23-002448 filed Feb 7, 202316.5a35.015.5aQ4 FY2021Q3 FY2023Q4 FY2022
Q4 FY2022
16.5a$M
derived
All values (45)
PeriodValue ($M)Status
Q1 FY202748.2reported
Q4 FY202650.2derived
Q3 FY202649.1reported
Q2 FY202648.8reported
Q1 FY202650.4reported
Q4 FY202587.8derived
Q3 FY202549.5reported
Q2 FY202547.3reported
Q1 FY202544.8reported
Q4 FY202442.9derived
Q3 FY202442.6reported
Q2 FY202445.3reported
Q1 FY202440.4reported
Q4 FY202336.3derived
Q3 FY202335.0reported
Q2 FY202329.9reported
Q1 FY202322.3reported
Q4 FY202216.5derived
Q3 FY202216.0reported
Q2 FY202216.1reported
Q1 FY202212.5reported
Q4 FY202115.5derived
Q3 FY202114.0reported
Q2 FY202113.7reported
Q1 FY202112.4reported
Q4 FY202012.5derived
Q3 FY202012.3reported
Q2 FY202012.0reported
Q1 FY202011.3reported
Q4 FY201911.1derived
Q3 FY201910.1reported
Q2 FY20199.8reported
Q1 FY20199.3reported
Q4 FY20189.5derived
Q3 FY20187.9reported
Q2 FY201818.9reported
Q1 FY20187.7reported
Q4 FY20178.4derived
Q3 FY20177.5reported
Q2 FY20177.5reported
Q1 FY20177.4reported
Q4 FY20167.3derived
Q3 FY20167.5reported
Q2 FY20167.4reported
Q1 FY20166.6reported

CSV with all sources · Technical ID: dna

More metrics for Take-Two

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$16.0M (derived)
Period
Q4 FY2022, ended Mar 31, 2022 · quarterly value (3 months, not cumulative)
Calculation
Q4 = fiscal year − 9 months cumulative = 61M − 45M = $16.0M (FY value from 10-K 0001628280-23-019851; 9-month value from the Q3-10-Q)
Source
10-K, filed May 26, 2023 · 0001628280-23-019851
Location
us-gaap:DepreciationDepletionAndAmortization
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$16.0MMay 26, 202310-K 0001628280-23-019851derived · confidence 1. · current